Cost-effectiveness of budesonid/formoterol inhaler in treatment of moderate bronchial asthma

P. A. Vorobyev, M. V. Aksentyeva, M. S. Smirnova (Moscow, Russian Federation)

Source: Annual Congress 2006 - Asthma - miscellaneous issues
Session: Asthma - miscellaneous issues
Session type: Electronic Poster Session
Number: 2882
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. A. Vorobyev, M. V. Aksentyeva, M. S. Smirnova (Moscow, Russian Federation). Cost-effectiveness of budesonid/formoterol inhaler in treatment of moderate bronchial asthma. Eur Respir J 2006; 28: Suppl. 50, 2882

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cost-effectiveness of fluticasone/salmeterol inhaler in treatment of moderate and severe bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008


The effectiveness of seretide in children with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Novel combination inhaler for mild asthma treatment
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008


Improved and maintained asthma control with once-daily budesonide/formoterol single inhaler therapy in mild-to-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001

Utility of inhaled corticosteroids (fluticasone/formoterol) by pressurized metered-dose inhaler for the early management of acute exacerbations of asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010

Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003

Improved asthma control with budesonide/formoterol via a single inhaler, compared with budesonide alone, in moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001

Evaluation of adherence of patients with asthma to treatment by single combination inhaler
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006

Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006

The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 424s
Year: 2001

Efficacy, safety and cost of using beclomethason dipropionate in patients with persistent moderate bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Comparison of inhaler and nebuliser bronchodilator treatments in COPD attacks
Source: Eur Respir J 2002; 20: Suppl. 38, 244s
Year: 2002

Efficacy of symbicort administration in patients with bronchial asthma
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009


Influence of treatment by single combined inhaler on adherence of patients with asthma
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009


Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002

Budesonide/formoterol in a single inhaler once or twice daily provides better asthma control than inhaled fluticasone or budesonide alone in patients with moderate persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 387s
Year: 2002

The effect of inhaler switching on asthma and COPD patients
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018



Anti-inflammatory effect and clinical efficacy of concomitant treatments to steroid inhaler in bronchial asthma: montelukast versus salmeterol
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006